$1.270
+0.132 (+10.43%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CLRB por análisis de gráficos similares
Alphio's CLRB stock price prediction model matches the current Cellectar Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.23 (-3.47%). The 1-week path is $1.21 (-4.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Cellectar Biosciences Inc?
Cellectar Biosciences Inc is a good buy right now, trading at $1.27, significantly below its 52-week high of $4.70. The company has reported a strong 87.5% overall response rate in its clinical trials, indicating promising drug efficacy. Additionally, the recent financing of $35 million provides a solid financial foundation to support its operations into mid-2027, which is crucial for ongoing clinical trials.
CLRB cerró en $1.27 el Friday, tras subir +10.43%
Cellectar Biosciences Inc (CLRB) last closed at $1.27, gaining +10.43%. These facts feed the 1-day and 1-week CLRB price prediction above.
Factores de la previsión
Los factores de la previsión de Cellectar Biosciences Inc (CLRB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CLRB, ordenadas por similitud.
Análisis de estacionalidad de CLRB
Historically the probability of a positive November return for CLRB is 0.00%. January offers the highest probability of a positive month at 50.82%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CLRB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $4.46 | $4.66 | $4.73 | +266.76% |
| Dec 2026 | $5.12 | $5.89 | $6.85 | +364.12% |
En 2026, se proyecta que Cellectar Biosciences Inc (CLRB) oscile entre $4.46 y $6.85.
Previsión mensual de Cellectar Biosciences Inc para 2026
En Nov de 2026, se proyecta que Cellectar Biosciences Inc promedie $4.66, con un mínimo de $4.46 y un máximo de $4.73.
En Dec de 2026, se proyecta que Cellectar Biosciences Inc promedie $5.89, con un mínimo de $5.12 y un máximo de $6.85.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.